Dependence of gonadotropin-releasing hormone-induced neuronal MAPK signaling on epidermal growth factor receptor transactivation

被引:58
作者
Shah, BH
Soh, JW
Catt, KJ
机构
[1] NICHD, ERRB, NIH, Bethesda, MD 20892 USA
[2] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA
关键词
D O I
10.1074/jbc.m208783200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The hypothalamic decapeptide, gonadotropin-releasing hormone (GnRH), utilizes multiple signaling pathways to activate extracellularly regulated mitogen-activated protein kinases (ERK1/2) in normal and immortalized pituitary gonadotrophs and transfected cells expressing the GnRH receptor. In immortalized hypothalamic GnRH neurons (GT1-7 cells), which also express GnRH receptors, GnRH, epidermal growth factor (EGF), and phorbol 12-myristate 13-acetate (PMA) caused marked phosphorylation of ERK1/2. This action of GnRH and PMA but not that of EGF, was primarily dependent on activation of protein kinase C (PKC), and the ERK1/2 responses to all three agents were abolished by the selective EGF receptor kinase inhibitor, AG1478. Consistent with this, both GnRH and EGF increased tyrosine phosphorylation of the EGF receptor. GnRH and PMA, but not EGF, caused rapid phosphorylation of the proline-rich tyrosine kinase, Pyk2, at Tyr(402). This was reduced by Ca2+ chelation and inhibition of PKC, but not by AG1478. GnRH stimulation caused translocation of PKCalpha and -epsilon to the cell membrane and enhanced the association of Src with PKCalpha and PKCepsilon, Pyk2, and the EGF receptor. The Src inhibitor, PP2, the C-terminal Src kinase (Csk), and dominant-negative Pyk2 attenuated ERK1/2 activation by GnRH and PMA but not by EGF. These findings indicate that Src and Pyk2 act upstream of the EGF receptor to mediate its transactivation, which is essential for GnRH-induced ERK1/2 phosphorylation in hypothalamic GnRH neurons.
引用
收藏
页码:2866 / 2875
页数:10
相关论文
共 58 条
[1]   Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade [J].
Andreev, J ;
Galisteo, ML ;
Kranenburg, O ;
Logan, SK ;
Chiu, ES ;
Okigaki, M ;
Cary, LA ;
Moolenaar, WH ;
Schlessinger, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :20130-20135
[2]   RAFTK/Pyk2-mediated cellular signalling [J].
Avraham, H ;
Park, SY ;
Schinkmann, K ;
Avraham, S .
CELLULAR SIGNALLING, 2000, 12 (03) :123-133
[3]   RETRACTED: Role of dynamin, Src, and Ras in the protein kinase C-mediated activation of ERK by gonadotropin-releasing hormone (Retracted article. See vol. 292, pg. 8855, 2017) [J].
Benard, O ;
Naor, Z ;
Seger, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (07) :4554-4563
[4]   Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades [J].
Blaukat, A ;
Ivankovic-Dikic, I ;
Grönroos, E ;
Dolfi, F ;
Tokiwa, G ;
Vuori, K ;
Dikic, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (21) :14893-14901
[5]   Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors [J].
Daub, H ;
Weiss, FU ;
Wallasch, C ;
Ullrich, A .
NATURE, 1996, 379 (6565) :557-560
[6]   Signal characteristics of G protein-transactivated EGF receptor [J].
Daub, H ;
Wallasch, C ;
Lankenau, A ;
Herrlich, A ;
Ullrich, A .
EMBO JOURNAL, 1997, 16 (23) :7032-7044
[7]  
DELAESCALERA GM, 1992, ENDOCRINOLOGY, V131, P1397
[8]   Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase cascade - Role of focal adhesions and receptor tyrosine kinases [J].
Della Rocca, GJ ;
Maudsley, S ;
Daaka, Y ;
Lefkowitz, RJ ;
Luttrell, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (20) :13978-13984
[9]   A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation [J].
Dikic, I ;
Tokiwa, G ;
Lev, S ;
Courtneidge, SA ;
Schlessinger, J .
NATURE, 1996, 383 (6600) :547-550
[10]   Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells [J].
Eguchi, S ;
Iwasaki, H ;
Inagami, T ;
Numaguchi, K ;
Yamakawa, T ;
Motley, ED ;
Owada, KM ;
Marumo, F ;
Hirata, Y .
HYPERTENSION, 1999, 33 (01) :201-206